Search Results

Filter
  • 1-10 of  101,128 results for ""Antibodies, Viral""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes.

  • Authors : Mikolajek H; Electron Bio-Imaging Centre, Diamond Light Source, Didcot OX11 0DE, United Kingdom.; Protein Production UK, The Research Complex at Harwell, Didcot OX11 OFA, United Kingdom.

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/chemistry ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/genetics ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/chemistry

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Aug 02; Vol. 119 (31), pp. e2205412119. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.

  • Authors : Banerjee A; Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.; Huang J

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/chemistry ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/isolation & purification ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jun 21; Vol. 119 (25), pp. e2203326119. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Editorial & Opinion

Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology ; Immunity, Active*/Immunity, Active*/Immunity, Active*/immunology

  • Source: The New England journal of medicine [N Engl J Med] 2022 Aug 11; Vol. 387 (6), pp. 568-570. Date of Electronic Publication: 2022 Jul 20.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.

  • Authors : Syed AM; Gladstone Institutes, San Francisco, CA 94158.; Innovative Genomics Institute, University of California, Berkeley, CA 94720.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/therapeutic use SARS-CoV-2 variants

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Aug 02; Vol. 119 (31), pp. e2200592119. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Antibody response following a Comirnaty booster dose in CoronaVac vaccinated individuals.

  • Authors : Bochnia-Bueno L; Virology Laboratory, Federal University of Paraná, Curitiba, Brazil; Graduate Program in Microbiology, Parasitology and Pathology, Federal University of Paraná, Curitiba, PR, Brazil.

Subjects: Antibodies, Viral* ; Antibody Formation*; Enzyme-Linked Immunosorbent Assay

  • Source: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2022 Aug; Vol. 103 (4), pp. 115730. Date of Electronic Publication: 2022 May 26.Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Vaccination, Transplantation, and a Social Contract.

  • Authors : Kates OS; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland .; Limaye AP

Subjects: Antibodies, Viral* ; Vaccination*

  • Source: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2022 Aug; Vol. 33 (8), pp. 1445-1447. Date of Electronic Publication: 2022 May 11.Publisher: American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study.

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2022 Aug; Vol. 28 (8), pp. Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691

Record details

×
Academic Journal

A broad and potent neutralization epitope in SARS-related coronaviruses.

  • Authors : Yuan M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.; Zhu X

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/immunology ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology SARS-CoV-2 variants

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jul 19; Vol. 119 (29), pp. e2205784119. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.

  • Authors : Jones JM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.; Opsomer JD

Subjects: Antibodies, Viral* ; Blood Donors*/Blood Donors*/Blood Donors*/statistics & numerical data ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: JAMA [JAMA] 2022 Jul 19; Vol. 328 (3), pp. 298-301.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.

  • Authors : Chan CE; Biological Defence Programme, DSO National Laboratoriesgrid.410760.4, Singapore, Republic of Singapore.; Infectious Disease Laboratory, National Centre for Infectious Diseases, Singapore, Republic of Singapore.

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/metabolism ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/metabolism ; COVID-19*

  • Source: Journal of virology [J Virol] 2022 Jul 13; Vol. 96 (13), pp. e0045522. Date of Electronic Publication: 2022 Jun 21.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  101,128 results for ""Antibodies, Viral""